Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04504955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

StatusRecruiting
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Recruiting
    • Site details revised
    v7
  2. Study Identification, Study Status, Oversightv6
  3. Eligibility criteria expanded, about 10 words
    • Study description shortened, about 168 words
    • Study site revised
    • Study title revised
    v5
  4. 2 versions Re-verified since Mar 6, 2023, no change to tracked fieldsv3-v4
  5. Eligibility criteria expanded, about 88 wordsv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis under the care of a licensed dermatologist or qualified physician extender. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices. Condition or disease : Atopic Dermatitis
Trial Details
NCT Number NCT04504955
Lead Sponsor CorEvitas
Conditions
(from sponsor)		 Atopic Dermatitis
Related terms Dermatitis, Atopic
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov